Targeting the BCL-2 family in malignancies of germinal centre origin

Bibliography

• MacLennan IC. Germinal centers. Annu Rev Immunol 1994;12117-39
   PubMed Web of Science ®Google Scholar
• Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science 2007;315(5811):528-31
   PubMed Web of Science ®Google Scholar
• Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007;27(2):190-202
   PubMed Web of Science ®Google Scholar
• Berard M, Mondiere P, Casamayor-Palleja M, Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. J Immunol 1999;163(9):4655-62
   PubMed Web of Science ®Google Scholar
• van Eijk M, Defrance T, Hennino A, de Groot C. Death-receptor contribution to the germinal-center reaction. Trends Immunol 2001;22(12):677-82
   PubMed Web of Science ®Google Scholar
• Inman GJ, Allday MJ. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent. J Immunol 2000;165(5):2500-10
   PubMed Web of Science ®Google Scholar
• Briere F, Defrance T, Vanbervliet B, Transforming growth factor beta (TGF beta) directs IgA1 and IgA2 switching in human naive B cells. Adv Exp Med Biol 1995;371A21-6
   PubMedGoogle Scholar
• Cazac BB, Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000;13(4):443-51
   PubMed Web of Science ®Google Scholar
• Borsutzky S, Cazac BB, Roes J, Guzman CA. TGF-beta receptor signaling is critical for mucosal IgA responses. J Immunol 2004;173(5):3305-9
   PubMed Web of Science ®Google Scholar
• Lebman DA, Edmiston JS. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect 1999;1(15):1297-304
   PubMed Web of Science ®Google Scholar
• Spender LC, O'Brien DI, Simpson D, TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ 2009;16(4):593-602
   PubMed Web of Science ®Google Scholar
• Dong M, Blobe GC. Role of transforming growth factor-beta in hematologic malignancies. Blood 2006;107(12):4589-96
   PubMed Web of Science ®Google Scholar
• Kondo E, Yoshino T. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis. Pathol Int 2007;57(7):391-7
   PubMed Web of Science ®Google Scholar
• Lin B, Kolluri SK, Lin F, Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004;116(4):527-40
   PubMed Web of Science ®Google Scholar
• Kolluri SK, Zhu X, Zhou X, A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 2008;14(4):285-98
   PubMed Web of Science ®Google Scholar
• Luciano F, Krajewska M, Ortiz-Rubio P, Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma. Blood 2007;109(9):3849-55
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Cerasoli DM, Dal Porto JM, Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-xL transgenic mice. J Exp Med 1999;190(3):399-410
   PubMed Web of Science ®Google Scholar
• Tuscano JM, Druey KM, Riva A, Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 1996;88(4):1359-64
   PubMed Web of Science ®Google Scholar
• Saltzman A, Munro R, Searfoss G, Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Exp Cell Res 1998;242(1):244-54
   PubMed Web of Science ®Google Scholar
• Grillot DA, Merino R, Pena JC, bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med 1996;183(2):381-91
   PubMed Web of Science ®Google Scholar
• Zhang X, Li L, Choe J, Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell Immunol 1996;173(1):149-54
   PubMed Web of Science ®Google Scholar
• Nakayama K, Nakayama K, Negishi I, Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 1993;261(5128):1584-8
   PubMed Web of Science ®Google Scholar
• Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993;75(2):229-40
   PubMed Web of Science ®Google Scholar
• Martinez-Valdez H, Guret C, de Bouteiller O, Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 1996;183(3):971-7
   PubMed Web of Science ®Google Scholar
• McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991;349(6306):254-6
   PubMed Web of Science ®Google Scholar
• Klein U, Tu Y, Stolovitzky GA, Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci USA 2003;100(5):2639-44
   PubMed Web of Science ®Google Scholar
• Caron G, Le Gallou S, Lamy T, CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells. J Immunol 2009;182(12):7595-602
   PubMed Web of Science ®Google Scholar
• Coultas L, Bouillet P, Stanley EG, Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol 2004;24(4):1570-81
   PubMed Web of Science ®Google Scholar
• Craxton A, Chuang PI, Shu G, The CD40-inducible Bcl-2 family member A1 protects B cells from antigen receptor-mediated apoptosis. Cell Immunol 2000;200(1):56-62
   PubMed Web of Science ®Google Scholar
• Jiang A, Clark EA. Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J Immunol 2001;166(10):6025-33
   PubMed Web of Science ®Google Scholar
• O'Connor L, Strasser A, O'Reilly LA, Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J 1998;17(2):384-95
   PubMed Web of Science ®Google Scholar
• Gomez-Bougie P, Bataille R, Amiot M. Endogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cells. Eur J Immunol 2005;35(3):971-6
   PubMed Web of Science ®Google Scholar
• Clybouw C, McHichi BE, Hadji A, TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL. Oncogene 2008;27(24):3446-56
   PubMed Web of Science ®Google Scholar
• Enders A, Bouillet P, Puthalakath H, Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 2003;198(7):1119-26
   PubMed Web of Science ®Google Scholar
• Goodyear CS, Corr M, Sugiyama F, Cutting Edge: Bim is required for superantigen-mediated B cell death. J Immunol 2007;178(5):2636-40
   PubMed Web of Science ®Google Scholar
• Fischer SF, Bouillet P, O'Donnell K, Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood 2007;110(12):3978-84
   PubMed Web of Science ®Google Scholar
• Erlacher M, Labi V, Manzl C, Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006;203(13):2939-51
   PubMed Web of Science ®Google Scholar
• Hutcheson J, Scatizzi JC, Bickel E, Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis. J Exp Med 2005;201(12):1949-60
   PubMed Web of Science ®Google Scholar
• Coultas L, Bouillet P, Loveland KL, Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis. Embo J 2005 24(22):3963-73
   PubMed Web of Science ®Google Scholar
• Balmanno K, Cook SJ. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 2009;16(3):368-77
   PubMed Web of Science ®Google Scholar
• Tabrizi SJ, Niiro H, Masui M, T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. J Immunol 2009;182(3):1490-9
   PubMed Web of Science ®Google Scholar
• Clybouw C, Hadji A, ElMchichi B, BimL upregulation induced by BCR cross-linking in BL41 Burkitt's lymphoma results from a splicing mechanism of the BimEL mRNA. Biochem Biophys Res Commun 2009;383(1):32-6
   PubMed Web of Science ®Google Scholar
• Banerjee A, Grumont R, Gugasyan R, NF-κB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms. Blood 2008;112(13):5063-73
   PubMed Web of Science ®Google Scholar
• O'Reilly LA, Kruse EA, Puthalakath H, MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation. J Immunol 2009;183(1):261-9
   PubMed Web of Science ®Google Scholar
• Stang SL, Lopez-Campistrous A, Song X, A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells. Exp Hematol 2009;37(1):122-34
   PubMed Web of Science ®Google Scholar
• Richards S, Watanabe C, Santos L, Regulation of B-cell entry into the cell cycle. Immunol Rev 2008;224183-200
   PubMed Web of Science ®Google Scholar
• Opferman JT, Letai A, Beard C, Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003;426(6967):671-6
   PubMed Web of Science ®Google Scholar
• Woodland RT, Fox CJ, Schmidt MR, Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008;111(2):750-60
   PubMed Web of Science ®Google Scholar
• Labi V, Erlacher M, Kiessling S, Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development. J Exp Med 2008;205(3):641-55
   PubMed Web of Science ®Google Scholar
• Kuss AW, Knodel M, Berberich-Siebelt F, A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. Eur J Immunol 1999;29(10):3077-88
   PubMed Web of Science ®Google Scholar
• Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999;13(4):400-11
   PubMed Web of Science ®Google Scholar
• Edelstein LC, Lagos L, Simmons M, NF-κB-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1. Mol Cell Biol 2003;23(8):2749-61
   PubMed Web of Science ®Google Scholar
• Pegman PM, Smith SM, D'Souza BN, Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJκ-dependent pathway. J Virol 2006;80(16):8133-44
   PubMed Web of Science ®Google Scholar
• Yoon SO, Zhang X, Berner P, Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis. J Immunol 2009;183(1):352-8
   PubMed Web of Science ®Google Scholar
• Imaizumi K, Benito A, Kiryu-Seo S, Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death. J Neurosci 2004;24(15):3721-5
   PubMed Web of Science ®Google Scholar
• Yin XM, Wang K, Gross A, Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999;400(6747):886-91
   PubMed Web of Science ®Google Scholar
• Villunger A, Michalak EM, Coultas L, p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003;302(5647):1036-8
   PubMed Web of Science ®Google Scholar
• Ranger AM, Zha J, Harada H, Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003;100(16):9324-9
   PubMed Web of Science ®Google Scholar
• Garrison SP, Jeffers JR, Yang C, Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 2008;28(17):5391-402
   PubMed Web of Science ®Google Scholar
• Michalak EM, Jansen ES, Happo L, Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ 2009;16(5):684-96
   PubMed Web of Science ®Google Scholar
• Erlacher M, Michalak EM, Kelly PN, BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 2005;106(13):4131-8
   PubMed Web of Science ®Google Scholar
• Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005;5(4):251-62
   PubMed Web of Science ®Google Scholar
• Dave SS, Fu K, Wright GW, Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006;354(23):2431-42
   PubMed Web of Science ®Google Scholar
• Efremov DG, Gobessi S, Longo PG. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells. Autoimmun Rev 2007;7(2):102-8
   PubMed Web of Science ®Google Scholar
• Monroe JG. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol 2006;6(4):283-94
   PubMed Web of Science ®Google Scholar
• Gobessi S, Laurenti L, Longo PG, Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia 2009;23(4):686-97
   PubMed Web of Science ®Google Scholar
• Habens F, Lapham AS, Dallman CL, Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes. Oncogene 2007;26(13):1910-9
   PubMed Web of Science ®Google Scholar
• Arena V, Martini M, Luongo M, Mutations of the BIK gene in human peripheral B-cell lymphomas. Genes Chromosomes Cancer 2003;38(1):91-6
   PubMed Web of Science ®Google Scholar
• Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 2007;109(1):271-80
   PubMed Web of Science ®Google Scholar
• Hemann MT, Bric A, Teruya-Feldstein J, Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005;436(7052):807-11
   PubMed Web of Science ®Google Scholar
• Leonard JP, Gregory SA, Maloney DG, Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma. Clin Adv Hematol Oncol 2008;6(6):437-45
   PubMedGoogle Scholar
• Bonavida B. Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions. Oncogene 2007;26(25):3629-36
   PubMed Web of Science ®Google Scholar
• Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-κB signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer Res 2005;65(1):264-76
   PubMed Web of Science ®Google Scholar
• Derenne S, Monia B, Dean NM, Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells. Blood 2002;100(1):194-9
   PubMed Web of Science ®Google Scholar
• van de Donk NW, Kamphuis MM, van Dijk M, Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein. Leukemia 2003;17(1):211-9
   PubMed Web of Science ®Google Scholar
• Morales AA, Olsson A, Celsing F, High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. Int J Cancer 2005;113(5):730-7
   PubMed Web of Science ®Google Scholar
• Brien G, Trescol-Biemont MC, Bonnefoy-Berard N. Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis. Oncogene 2007;26(39):5828-32
   PubMed Web of Science ®Google Scholar
• Olsson A, Norberg M, Okvist A, Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer 2007;97(6):769-77
   PubMed Web of Science ®Google Scholar
• Zhao WL, Daneshpouy ME, Mounier N, Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood 2004;103(2):695-7
   PubMed Web of Science ®Google Scholar
• Ghia P, Boussiotis VA, Schultze JL, Unbalanced expression of Bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 1998;91(1):244-51
   PubMed Web of Science ®Google Scholar
• Lessene G, Czabotar PE, Colman PM. BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov 2008;7(12):989-1000
   PubMed Web of Science ®Google Scholar
• Azmi AS, Mohammad RM. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. J Cell Physiol 2009;218(1):13-21
   PubMed Web of Science ®Google Scholar
• Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009;15(4):1126-32
   PubMed Web of Science ®Google Scholar
• Balakrishnan K, Wierda WG, Keating MJ, Gandhi V. Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells. Blood 2008;112(5):1971-80
   PubMed Web of Science ®Google Scholar
• Perez-Galan P, Roue G, Lopez-Guerra M, BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells. Leukemia 2008;22(9):1712-20
   PubMed Web of Science ®Google Scholar
• Paoluzzi L, Gonen M, Gardner JR, Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. Blood 2008;111(11):5350-8
   PubMed Web of Science ®Google Scholar
• van Delft MF, Wei AH, Mason KD, The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006;10(5):389-99
   PubMed Web of Science ®Google Scholar
• Labi V, Grespi F, Baumgartner F, Villunger A. Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy? Cell Death Differ 2008;15(6):977-87
   PubMed Web of Science ®Google Scholar
• Stolz C, Hess G, Hahnel PS, Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis. Blood 2008;112(8):3312-21
   PubMed Web of Science ®Google Scholar
• Whitecross KF, Alsop AE, Cluse LA, Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors. Blood 2009;113(9):1982-91
   PubMed Web of Science ®Google Scholar
• Paoluzzi L, Gonen M, Bhagat G, The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies. Blood 2008;112(7):2906-16
   PubMed Web of Science ®Google Scholar
• Kline MP, Rajkumar SV, Timm MM, ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells. Leukemia 2007;21(7):1549-60
   PubMed Web of Science ®Google Scholar
• Vogler M, Dinsdale D, Sun XM, A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells. Cell Death Differ 2008;15(5):820-30
   PubMed Web of Science ®Google Scholar
• Jayanthan A, Howard SC, Trippett T, Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737. Leuk Lymphoma 2009;50(7):1174-82
   PubMed Web of Science ®Google Scholar
• Del Gaizo Moore V, Brown JR, Certo M, Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest 2007;117(1):112-21
   PubMed Web of Science ®Google Scholar
• Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004;432(7017):635-9
   PubMed Web of Science ®Google Scholar
• Kashatus D, Cogswell P, Baldwin AS. Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes Dev 2006;20(2):225-35
   PubMed Web of Science ®Google Scholar
• Hennino A, Berard M, Krammer PH, Defrance T. FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J Exp Med 2001;193(4):447-58
   PubMed Web of Science ®Google Scholar
• van Eijk M, Medema JP, de Groot C. Cutting edge: cellular Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein protects germinal center B cells from apoptosis during germinal center reactions. J Immunol 2001;166(11):6473-6
   PubMed Web of Science ®Google Scholar
• Inman GJ, Nicolas FJ, Callahan JF, SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002;62(1):65-74
   PubMed Web of Science ®Google Scholar
• Yoshida T, Higuchi T, Hagiyama H, Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Int Immunol 2000;12(4):517-26
   PubMed Web of Science ®Google Scholar
• Ngan BY, Chen-Levy Z, Weiss LM, Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 1988;318(25):1638-44
   PubMed Web of Science ®Google Scholar
• George NM, Evans JJ, Luo X. A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax. Genes Dev 2007;21(15):1937-48
   PubMed Web of Science ®Google Scholar
• Letai A, Bassik MC, Walensky LD, Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002;2(3):183-92
   PubMed Web of Science ®Google Scholar
• Kim H, Rafiuddin-Shah M, Tu HC, Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 2006;8(12):1348-58
   PubMed Web of Science ®Google Scholar
• Gallenne T, Gautier F, Oliver L, Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol 2009;185(2):279-90
   PubMed Web of Science ®Google Scholar
• Chen L, Willis SN, Wei A, Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005;17(3):393-403
   PubMed Web of Science ®Google Scholar
• Certo M, Del Gaizo Moore V, Nishino M, Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006;9(5):351-65
   PubMed Web of Science ®Google Scholar
• Willis SN, Fletcher JI, Kaufmann T, Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007;315(5813):856-9
   PubMed Web of Science ®Google Scholar
• Mittelstadt PR, DeFranco AL. Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J Immunol 1993;150(11):4822-32
   PubMed Web of Science ®Google Scholar
• Krajewski S, Bodrug S, Gascoyne R, Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994;145(3):515-25
   PubMed Web of Science ®Google Scholar
• Kitada S, Andersen J, Akar S, Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998;91(9):3379-89
   PubMed Web of Science ®Google Scholar